264 related articles for article (PubMed ID: 10397742)
1. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
[TBL] [Abstract][Full Text] [Related]
3. ATM mutations in B-cell chronic lymphocytic leukemia.
Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
[TBL] [Abstract][Full Text] [Related]
4. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
5. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
6. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
7. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
[TBL] [Abstract][Full Text] [Related]
9. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
[TBL] [Abstract][Full Text] [Related]
11. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
[TBL] [Abstract][Full Text] [Related]
12. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Milani R; Bardi A; Minotto C; Agostini P; De Angeli C; Narducci MG; Sabbioni S; Russo G; Negrini M; Castoldi G
J Clin Oncol; 2000 Jul; 18(13):2607-14. PubMed ID: 10893293
[TBL] [Abstract][Full Text] [Related]
13. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
[TBL] [Abstract][Full Text] [Related]
14. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
15. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
[TBL] [Abstract][Full Text] [Related]
16. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
Skowronska A; Austen B; Powell JE; Weston V; Oscier DG; Dyer MJ; Matutes E; Pratt G; Fegan C; Moss P; Taylor MA; Stankovic T
Haematologica; 2012 Jan; 97(1):142-6. PubMed ID: 21933854
[TBL] [Abstract][Full Text] [Related]
17. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
Kalla C; Nentwich H; Schlotter M; Mertens D; Wildenberger K; Döhner H; Stilgenbauer S; Lichter P
Genes Chromosomes Cancer; 2005 Feb; 42(2):128-43. PubMed ID: 15543602
[TBL] [Abstract][Full Text] [Related]
18. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
19. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia.
Bevan S; Catovsky D; Marossy A; Matutes E; Popat S; Antonovic P; Bell A; Berrebi A; Gaminara E; Quabeck K; Ribeiro I; Mauro FR; Stark P; Sykes H; van Dongen J; Wimperis J; Wright S; Yuille MR; Houlston RS
Leukemia; 1999 Oct; 13(10):1497-500. PubMed ID: 10516748
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
